← Open Payments lookup

ABID DARR: Open Payments

NPI 1871940783 · LEESBURG, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,000 in 46 payments from 10 companies in 2025. Trend: 2023 $907 · 2024 $711 · 2025 $1,000

Food & beverage: $1,000
CompanyPaymentsAmount
Alkermes, Inc.9$192
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)5$157
Teva Pharmaceuticals USA, Inc.8$151
E.R. Squibb & Sons, L.L.C.5$100
Luye Pharma (USA) Ltd.4$92
Neurocrine BioSciences, Inc.4$88
Otsuka America Pharmaceutical, Inc.4$73
Axsome Therapeutics, Inc.3$66
Janssen Pharmaceuticals, Inc3$61
Vanda Pharmaceuticals Inc.1$21

Products named: CAPLYTA, UZEDY, ARISTADA, COBENFY, ERZOFRI EXTENDED-RELEASE, INGREZZA, ABILIFY MAINTENA, Auvelity.

Industry payments across FL — which companies pay providers there.